330 likes | 1.15k Views
Atrophic Rhinitis ’ Ozena ’. Bastaninejad , Shahin , MD, ORL & HNS, TUMS Amiralam Hospital. Presentation Outlines. Definition Pathophysiology Clinical presentations Differential diagnosis Investigations Treatment.
E N D
Atrophic Rhinitis’Ozena’ Bastaninejad, Shahin, MD, ORL & HNS, TUMS Amiralam Hospital
Presentation Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment
Atrophic rhinitis (AR) is a chronic and degenerative disease of the nasal & paranasal mucosa & other structures
Definition (Cont’) • triad of characteristic fetor, greenish crusts and roomy nasal cavitiesthis triad is diagnostic of the condition • Prevalence of Primary AR0.3-1% in high prevalence countries • High Prevalence countries are: India, Pakistan, China, Philippines, Malaysia, Saudi Arabia, Egypt and South america
Definition (Cont’) • Primary AR: More common in females(*6), usually bilateral, Prevalent in young and middle age adults • Often, no underlying etiology is discovered, although inheritable or infectious causes (58.7% K. ozena) are proposed mechanisms • there is however little evidence to suggest bacterial organisms cause the disease, they may be secondary invaders
Definition (Cont’) • Secondary AR: • Complication of sinus surgery (89%) • FESS in CRS > FESS in Polypoid CRS • In Mayo clinic assay : Partial MT and/or IT resection was the most common cause • Complication of radiation (2.5%) • Following nasal trauma (1%) • Sequela of granulomatous diseases (1%) and other infections : TB, Sarcoidosis, Leprosy, Rhinoscleroma, Syphilis
Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment
Pathophysiology • Nl. Respiratory epithelium (Pseudostratified Columnar) metaplastic changes cuboidal/stratified squamous epithelium • Atrophy of cilia and the mucosal and submucosalgland • Secondary bac. Infection produce a foetidodour • Osteitis of inferior turbinates and ethmoidturbinates • Vascular involvement (mainly endarteritisobliterans)
Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment
Clinical Features (Symptoms) • Nose emits a foul smell due to crusting and secondary infections (main characteristic). • Anosmia, cacosmia • Nasal obstruction • Headache • Thick purulent discharge with a foul smell (due to the anaerobic bacteria) • Minor bleeds due to dislodgment of crusts • Complain of dryness in the nose and throat (pharyngitissicca)
Clinical Features (signs) • Greenish yellow and black crusts (Crusts 100% present), bleeding and ulcerated mucosa is seen when crusts are separated • Patient is usually gloomy • Foetor (detected from distance) • Wide capacity of the nasal passages, Shrinkage of inferior and middle turbinates • Insensitivity of nasal mucosa (probe test) • Septal perforation, myiasis, saddle nose &… may be seen
Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment
Differential diagnosis • TB • Leprosy • Scleroma • Syphilis • Chronic sinus suppuration on its own • Suppurating adenoidal disease • Neglected FB / rhinoliths • Wegner’s disease • Chronic fungal rhinosinusitis • Empty nose syndrome (ENS) Kern & Stenkvist at 1994
What is ENS? ENS is an iatrogenic disorder most often recognized by thepresence of paradoxical nasal obstruction despite an objectively wide nasal fossa
ENS vs. Secondary AR • The resorption of the turbinate and adjacent mucosal tissue that results from atrophic rhinitis is reflective of the underlying pathophysiology of the disease, whereas ENS is an iatrogenic disorder • Secondary AR may also be the result of a multitude of other factors, including trauma, infection, or immunologic disorders. • Atrophic rhinitis has clear pathogenic links to organisms isolated from nasal cultures, but as of yet, there is no pathogen associated with ENS
Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment
Investigations • Hematologic study (CBC/diff) • ESR • FBS • C-ANCA, VDRL • PPD • CXR • PNS CT-Scan • Nasal swab for culture • Nasal Bx tested for bacteriological and morphological indices
Outlines • Definition • Pathophysiology • Clinical presentations • Differential diagnosis • Investigations • Treatment
Treatment (Medical) • Conservative management is the mainstay of the treatment • No cure available • Decongestants or antihistamines: strongly contraindicates • Nasal irrigation and douches: • With Alkaline douches (preferred) • With N/S or antibiotic+N/S douches
Treatment (Medical) • An ideal alkaline nasal douche mixture: • Sodium bicarbinate 25g • Sodium biborate 25g • Sodium chloride 50g • One teaspoonful of this mixture in 250cc lukewarm water, tds or qid, for 6wk, with a 10 to 20cc syringe • Instruct the patient to bend forward during the procedure and keep saying K K K…
Treatment (Medical) • Glucose-glycerine nose drops • Anhydrous Glucose 25% (~15g) • Glycerine 60cc • Use this after nasal douching • You can also use Gentamicin or Chloramphenicol drops after nasal douching, too
Treatment (Medical) • Antibiotics: • Rifampicin 600mg daily for 12wk (generic cap. is 300mg – take 2 every morning) • Recently: Cipro 500-750mg bid for 1-3mo • Vitamin A , 12,500 IU/day up to two weeks. • Iron supplements (if the patient is anemic)
Treatment (Surgical) • Young’s Procedure • Modified Young’s procedures • Modification of modified Young • Implantation • Other approaches
Treatment(Surgical) • Young’s procedure • Circumferential flap elevation 1 cm cephalic to the alar rim • Complete closure of nostril • Staged second side in 3-6 months • Difficult to elevate circumferential flap
Modified Young • Staged second side with first side takedown in 6 mo • No vestibular stenosis on takedown
Treatment (Surgical) • Modification of the modified young’s:
Treatment (Surgical) • Implantation: uses Bone (Auto/homografts), Cartilages, ... Prostethic implants such as Plastipore, ... • Extrusion of the prosthetic implants occured 1 in 8 in Plastipore series, but in another prosthetic series it was occured as high as 80%
Silastic Sheet - Case: Primary AR - 12mopostop result (Otolaryngology–Head and Neck Surgery (2010)) Right Left
Treatment (surgical) • Other approaches: • Transferring the Stensen duct to the maxillary sinus antrum • Using a caldwell approach, translocating the lateral nasal wall more medially • Silastic obturator • ...
Presentation Conclusion Endoscopic Sinus Surgery Primary Atrophic Rhinitis 2ndAtrophic Rhinitis Functional Endoscopic Sinus Surgery ...Try to save nasal structures and mucosal layer as much as you can